Canine health company Hemopet received its fourth patent for the company's nutrigenomics portfolio.
Hemopet says its business strategy calls for launching nutrigenomic petfood supplements in 2012, formulas which are currently being tested in Europe.
“Our intellectual property protects and confirms Hemopet as a leader in nutrigenomic petfoods. It validates our being at the forefront of petfood issues and further builds on our philosophy of individualized care for pets,” said Dr. Jean Dodds, president.
Feature
By Lindsay Beaton
Pet food label modernization still a work in progress
As work continues on creating a new nutrition label that focuses on simplifying information for consumers, challenges remain.
READ MORE in Petfood Industry magazine
Feature
By Tang Yu
5 insights on China’s pet food market post-2020
Data and observations sum up how the Chinese pet food market fared in 2020, while local pet food businesses and experts offer outlooks for 2021.